Literature DB >> 6692321

Does clearing of axillary lymph nodes contribute to accurate staging of breast carcinoma?

M Morrow, J Evans, P P Rosen, D W Kinne.   

Abstract

The major prognostic indicator in carcinoma of the breast is the presence of metastases in axillary lymph nodes. However, 25% of patients with negative axilliary nodes by standard pathologic techniques are dead of metastatic breast carcinoma within 10 years. "Clearing" of the axillary fat has been shown to increase the yield of lymph nodes. Forty-two pathologic Stage I and II breast carcinoma specimens were cleared following routine pathologic examination to determine whether stage was changed by the clearing procedure. A total of 857 lymph nodes were recovered from 42 patients by routine techniques. Clearing increased the number of nodes found by 30%, to 1114. In the 31 node-negative patients an additional 178 nodes were identified, increasing the mean number of nodes per patient from 20 to 26. The number of additional nodes found per specimen ranged from 0 to 19. None of the additional nodes identified contained metastases. In the node-positive patients, 79 additional nodes were found by clearing, including 33 with metastases. No change in stage resulted, although the mean number of nodes per patient was increased from 22 to 30. Although an occasional positive lymph node may be overlooked by manual dissection, the rarity of this event makes routine clearing of the axillary contents impractical for carcinoma of the breast except in a research setting. Whether this conclusion applies equally to other tumors and other lymph node groups requires further study.

Entities:  

Mesh:

Year:  1984        PMID: 6692321     DOI: 10.1002/1097-0142(19840315)53:6<1329::aid-cncr2820530618>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  U.K. National Breast Screening Programme: first year experience at a histopathology department in an assessment/treating centre.

Authors:  S Shousha
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer.

Authors:  Qian Yang; Xiao-dong Wang; Jie Chen; Chun-xiang Tian; Hong-jiang Li; Yu-Juan Chen; Qing Lv
Journal:  Tumour Biol       Date:  2012-09-05

4.  What constitutes adequate study of axillary lymph nodes in breast cancer?

Authors:  W B Kingsley; G N Peters; J H Cheek
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

5.  Rotter's node metastases. Therapeutic and prognostic considerations in early breast carcinoma.

Authors:  H S Cody; R A Egeli; J A Urban
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

6.  Occult axillary lymph node metastases are of no prognostic significance in breast cancer.

Authors:  R R Millis; R Springall; A H S Lee; K Ryder; E R C Rytina; I S Fentiman
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.